Adaptive Biotechnologies Corpor

ADPT

$17.36

Name : Adaptive Biotechnologies Corpor

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $2,778,370,560.00

EPSttm : -0.32

Adaptive Biotechnologies Corpor

$17.36

3.95%

$0.66

ADPT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.76

Margin Of Safety %

Put/Call OI Ratio

0.21

EPS Next Q Diff

0.02

EPS Last/This Y

-0.07

EPS This/Next Y

0.2

Price

17.38

Target Price

20.14

Analyst Recom

1.25

Performance Q

19.56

Upside

-166.5%

Beta

2.1

Ticker: ADPT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ADPT	13.53	0.48	0.80	878
2026-05-12	ADPT	13.63	0.49	7.00	882
2026-05-13	ADPT	13.14	0.51	999.99	888
2026-05-14	ADPT	13.17	0.68	0.00	990
2026-05-15	ADPT	12.82	0.68	999.99	990
2026-05-18	ADPT	12.7	0.29	0.24	547
2026-05-19	ADPT	12.97	0.28	2.71	565
2026-05-20	ADPT	13.96	0.43	0.00	632
2026-05-21	ADPT	13.88	0.39	0.00	677
2026-05-22	ADPT	13.87	0.38	2.57	679
2026-05-26	ADPT	14.14	0.39	1.57	680
2026-05-27	ADPT	13.84	0.46	0.08	748
2026-05-28	ADPT	15.2	0.45	0.31	758
2026-05-29	ADPT	15.15	0.45	0.00	770
2026-06-02	ADPT	15.15	0.43	0.13	800
2026-06-03	ADPT	15.99	0.42	0.13	808
2026-06-04	ADPT	18.1	0.42	0.01	805
2026-06-05	ADPT	16.9	0.21	0.29	1391
2026-06-08	ADPT	16.7	0.21	0.06	1408
2026-06-09	ADPT	17.41	0.21	0.05	1420
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ADPT	13.52	25.9	-	-0.47
2026-05-12	ADPT	13.62	23.8	-	-0.46
2026-05-13	ADPT	13.13	23.8	-	-0.46
2026-05-14	ADPT	13.18	23.8	-	-0.46
2026-05-15	ADPT	12.82	23.8	-	-0.46
2026-05-18	ADPT	12.71	19.5	-	-0.47
2026-05-19	ADPT	12.96	19.5	-	-0.47
2026-05-20	ADPT	13.95	18.7	-	-0.46
2026-05-21	ADPT	13.88	18.7	-	-0.46
2026-05-22	ADPT	13.86	18.7	-	-0.46
2026-05-26	ADPT	14.14	18.7	-	-0.46
2026-05-27	ADPT	13.84	18.7	-	-0.46
2026-05-28	ADPT	15.21	18.7	-	-0.46
2026-05-29	ADPT	15.15	18.7	-	-0.46
2026-06-01	ADPT	15.24	18.7	-	-0.46
2026-06-02	ADPT	15.15	18.7	-	-0.46
2026-06-03	ADPT	15.98	18.7	-	-0.46
2026-06-04	ADPT	18.10	18.7	-	-0.46
2026-06-05	ADPT	16.89	18.7	-	-0.46
2026-06-08	ADPT	16.70	18.7	-	-0.46
2026-06-09	ADPT	17.38	20.3	-	-0.46
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ADPT	-42.63	1.43	5.55
2026-05-12	ADPT	-42.63	1.43	5.48
2026-05-13	ADPT	-42.08	1.43	5.48
2026-05-14	ADPT	-42.08	1.43	5.48
2026-05-15	ADPT	-42.08	1.43	5.48
2026-05-18	ADPT	-42.08	0.62	5.48
2026-05-19	ADPT	-42.08	0.62	5.48
2026-05-20	ADPT	-42.08	0.62	5.48
2026-05-21	ADPT	-42.10	0.62	5.48
2026-05-22	ADPT	-42.10	0.62	5.48
2026-05-26	ADPT	-38.50	1.49	5.48
2026-05-27	ADPT	-38.50	1.49	5.48
2026-05-28	ADPT	-38.50	1.49	5.78
2026-05-29	ADPT	-38.50	1.49	5.76
2026-06-02	ADPT	-39.17	0.81	5.76
2026-06-03	ADPT	-38.07	0.81	5.76
2026-06-04	ADPT	-38.07	0.81	5.76
2026-06-05	ADPT	-38.07	0.81	5.76
2026-06-08	ADPT	-37.81	0.78	5.76
2026-06-09	ADPT	-38.08	0.78	5.76
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.13

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.11

Insider Transactions

-38.08

Institutional Transactions

0.78

Beta

2.1

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-94.5

Target Price

20.14

P/E

Forward P/E

PEG

P/S

9.41

P/B

12.81

P/Free Cash Flow

EPS

-0.33

Average EPS Est. Cur. Y

-0.46

EPS Next Y. (Est.)

-0.25

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-16.82

Relative Volume

1.12

Return on Equity vs Sector %

-50.4

Return on Equity vs Industry %

-33.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

◆ ADPT Healthcare

$17.36

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

4/25

Volume

4/15

Valuation

8/20

TP/AR

2/10

Options

8/10

RSI

66.5

Range 1M

85.6%

Sup Dist

5.4%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

16/25

Growth

19/30

Estimates

2/20

Inst/Vol

8/15

Options

8/10

EPS Yr

-18.3%

EPS NY

46.6%

52W%

69.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +16% upside

Quality

6/30

Valuation

5/30

Growth

14/25

Stability

7/10

LT Trend

4/5

Upside

+16%

Quality

Adaptive Biotechnologies Corpor

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 624

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

ADPT

Latest News

—

Caricamento notizie per ADPT…

stock quote shares ADPT – Adaptive Biotechnologies Corporation Stock Price stock today

news today ADPT – Adaptive Biotechnologies Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch ADPT – Adaptive Biotechnologies Corporation yahoo finance google finance

stock history ADPT – Adaptive Biotechnologies Corporation invest stock market

stock prices ADPT premarket after hours

ticker ADPT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ADPT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y